REMICADE: FDA approves 1st cheaper version of J&J's top drug Remicade

WASHINGTON (AP) - Federal health officials have approved a cheaper version of Johnson & Johnson's blockbuster drug, Remicade, a pricey biotech medicine for inflammatory diseases. The approval of Inflectra Tuesday is only the second time that the Food and Drug Administration has approved a quasi-generic biotech drug for the U.S. market. These so-called biosimilar drugs, [...]